1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA PCDHA9 CTRPv2 pan-cancer AAC 0.093 0.01
mRNA PTPRM CTRPv2 pan-cancer AAC -0.089 0.01
mRNA DEDD CTRPv2 pan-cancer AAC 0.085 0.01
mRNA AP3D1 CTRPv2 pan-cancer AAC 0.083 0.01
mRNA MMD2 CTRPv2 pan-cancer AAC 0.082 0.01
mRNA FNDC3A CTRPv2 pan-cancer AAC 0.084 0.01
mRNA FNDC9 CTRPv2 pan-cancer AAC 0.093 0.01
mRNA AL365181.1 CTRPv2 pan-cancer AAC 0.085 0.01
mRNA ARHGAP26 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA CLASP1 CTRPv2 pan-cancer AAC 0.089 0.01
Download CSV